Mammography Market by Device Type (Analog Mammography Systems, Digital Mammography Systems, 3D Mammography Systems, Others.), By Portability (Stationary Mammography Systems, Portable Mammography Systems.), By End-User (Hospitals, Diagnostic Centres, Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, And Market Forecast, 2025 – 2035

Industry Outlook

The Mammography market accounted for USD 2.58 Billion in 2024 and is expected to reach USD 6.43 Billion by 2035, growing at a CAGR of around 8.65% between 2025 and 2035.  
The Mammography Market concerns technologies and devices used for the examination of breast cancer. Mammography is a procedure in which low-energy X-ray images are measured; possible lesions are tumors on the breast tissue. Equipment in this market includes digital mammography systems, 3D mammography or tomosynthesis machines, and analog systems.

The market is stimulated by a higher incidence of breast cancer, growing consciousness about the dreadful disease, and regular screening by the government. Some techniques include the use of artificial intelligence for analyzing images, all of which have improved diagnostic efficacy. Issues include relatively high costs as well as restricted availability of technologies in the developing world. There is also an aging population and a focus on development in women’s health.

Report Scope:

Market Dynamics

Rising breast cancer cases increase demand for screening and detection technologies.

The increasing number of patients with breast cancer is one of the strongest factors driving the growth of the Mammography Market as more people are diagnosed with it and seek ways to detect it earlier. To identify breast cancer before it has progressed and spread to other organs when the patient's chances of survival are high, mammography screening is especially crucial. Because of this, diseases like breast cancer, which affects one in eight women in the US at some point, continue to be a significant issue that people should get screened for at least once in their lives.

Given that breast cancer incidence is increasing, providers have increased spending on better and more available mammography devices. This trend is particularly observable in developed countries that have increased life expectancy and therefore an increased likelihood of developing breast cancer, owing to genetic factors. Upgraded detection modalities, including 3D mammograms, bring benefits to outcomes, thus promoting the Mammography Market.

AI-driven tools predict breast cancer risks, enhancing personalized screening approaches.

In the Mammography Market, AI solutions are emerging as crucial assets in improving the targeted strategies for screening. Some of the tools apply the best machine learning algorithms that can decipher the mammogram with high precision and reveal the early signs of breast cancer that might be undetectable by radiologists. AI reasoning reduces intervals between screening and early detection of breast cancer as it applies patients' screening schedules according to the calculated risk.

The U.S. NIH also reveals that AI models have a high efficiency in reading mammography by reducing the number of false positive and negative cases. As the number of cases of breast cancer rises globally, artificial intelligence (AI) is the technological innovation in mammography that offers better, faster, and more personalized breast cancer screening. This technology serves as a useful tool for radiologists as well, meeting all of their needs while offering high levels of confidence in cancer diagnosis. As a result, it contributes significantly to the development of cancer diagnosis technologies.

High mammography equipment costs limit adoption in low-income regions worldwide.

The high cost of mammography equipment, which could be prohibitive in low-income regions of the world, is a major factor that could impede the Mammography Market expansion. Despite the high initial costs of purchasing, maintaining, and operating sophisticated mammography equipment, healthcare institutions with little funding may not be able to afford the expenses.

Due to a lack of infrastructure, screening for the disease is practically impossible in remote areas or underdeveloped nations, where this expense makes screening services less accessible. As a result, few women in these areas have received the required cancer screening, which has led to later-stage diagnoses and poor health. However, research has shown that mammography may be used to identify cancer early, but the expense prevents most of the unreached population from using this effective tool.

AI integration can improve diagnostic accuracy and streamline mammogram analysis processes.

The integration of AI for mammography offers a new prospect for the Mammography Market by enhancing the diagnostic performance of mammography and increasing the efficiency of analysis of the mammography results. A mammogram can be analyzed with the help of AI-driven tools with higher accuracy, including details that a human can easily miss when interpreting the mammogram. They are capable of helping diagnose stage one breast cancer and lower the rate of false positive or negative results on screening.

Furthermore, many parts of the study can be completed much more quickly when AI is used. The advancement of technology improves the quality of healthcare delivery, allows for various patient screening methods based on risk factors, and facilitates the ability of healthcare institutions to serve a larger population due to rising demand. This is to help address the shortage of radiologists in some regions of the world. This technological advancement improves the quality of healthcare delivery, allows for various patient screening methods based on risk factors, and facilitates healthcare organizations' ability to serve a large number of patients due to rising demand.

Personalized medicine advancements create opportunities for combining genetic testing with mammography.

The Mammography Market has a significant opportunity by combining genetic testing with traditional mammography screenings as well as with advancements in personalized medicine. Genetic testing, like BRCA1 and BRCA2 mutations, helps identify women at a higher risk of breast cancer, enabling tailored screening schedules and more focused care. The approach, when integrated with mammography, enables early detection and accurate monitoring of high-risk patients, offering a personalized regimen based on genetic predispositions.

With the personally tailored approach, early interventions are better conducted, which then has an obvious positive impact on patient outcomes because cancer is detected at its most treatable stages. Moreover, merging genetic data with mammographic imaging will depict a much fuller image of individual breast cancer risks and drive market growth for personalized breast cancer screening technologies. With genetic testing integrated into the mammography process, healthcare providers can give further effective and targeted therapies, ultimately changing the prevention and management of breast cancer.

Industry Experts Opinion

"Digital 2D mammography has brought a great improvement in imaging clarity, which significantly enhances the detection of early breast cancers, particularly in women aged 45 to 70."

• Dr. Mary Lou Smith, Founder of the Breast Cancer Survivors Network

Segment Analysis

Based on the Device type, the Mammography Market has been classified into Analog Mammography Systems, Digital Mammography Systems, and 3D Mammography Systems. Digital mammography systems are the most prominent segment in the Mammography Market because this technology has almost completely replaced analog systems with better image quality, quicker processing speed, and ease of storing images in digital formats for more effective sharing and reviewing.

Digital systems, provide higher sensitivity to detect abnormalities and precision in diagnosis. As a result, digital mammography is now the most popular modality in clinical practice and screening, and it is in high demand in the market. In addition to being more affordable, technological developments are driving the adoption of these systems.

Based on the Portability, the Mammography Market has been classified into Stationary Mammography Systems, and Portable Mammography Systems. The most dominant segment in the Mammography Market is stationary mammography systems. These systems' dependability and outstanding image quality, as well as their capacity to process large numbers of screens, make them popular in hospitals and specialty imaging facilities.

Because of their exceptional diagnostic qualities, digital and 3D mammography are given more weight in the stationary, which indicates that they are frequently used in routine breast cancer screenings. While portable systems provide comfort and mobility, stationary systems are necessary for routine large-scale screening and accurate diagnostics, thus making them the market leader.

Regional Analysis

The North American Mammography Market is the largest due to the well-developed healthcare industry and the high usage of digital and 3D mammography systems. Some of the state intervention methods, such as breast cancer awareness and compulsory screening, have boosted early diagnosis greatly. Due to rising healthcare expenses and technological advancements like AI-based diagnostic applications, the US represents the largest market.

Canada also pays some of the cost because of increased awareness of breast cancer and rising healthcare spending, especially in the area of infrastructure development. This is accurate given that the Mammography Market continues to see ongoing product advancements and the presence of additional significant regional competitors.

The United States Mammography Market has the most significant market share because of increased awareness of breast cancer, a well-developed healthcare system, and a relatively high level of investment in the technology of mammography. The NBCCEDP and similar programs of the federal government fund other mass screening activities, therefore enhancing the outreach among the underserved.

Because of a potent combination of funding for research and development and robust FDA support, the adoption of new technology is already very high. All of these elements, together with expanding reimbursement guidelines and the strategic alliances between manufacturers and healthcare providers, contribute to the market's expansion. Furthermore, early detection has been successful, which is why so many hospitals and diagnostic facilities have mammography equipment.

The European Mammography Market has benefited from sound healthcare policies and high penetration of breast cancer screening across Europe. Germany, the UK, and France are deemed to be the most advanced markets mainly because the majority of their population enjoys good healthcare services and recognized government-sponsored programs that help increase awareness of early-stage breast cancer.

It is noteworthy that the European Breast Cancer Screening Guidelines have informed the high penetration of digital and 3D mammography technologies. Advanced diagnostic tools are emerging in the market because of AI progress, and diagnostic precision is improving with them. Technological advancement comes from research and synergy between healthcare facilities and active manufacturers in the industry.

The German Mammography Market is growing quickly because of easy access to medical facilities and increased government support for early identification of breast cancer. With its nationwide mammogram screening program for women over 50 and its emphasis on early detection, Germany has created a niche market for digital and 3D mammography equipment.

Healthcare in the country is well developed and offers the best technology products, such as artificial intelligence diagnostic systems that increase the efficiency of detection. Germany’s reimbursement policies also entitle the acquisition of modern mammography devices in the private and public sectors. Also, rising knowledge of breast cancer and sustained efforts and investments in medical research and healthcare advancement fuel the market’s growth.

Competitive Landscape

The Mammography Market's competitive landscape is shaped by major players like Hologic, Siemens Healthcare, GE HealthCare, and Fujifilm due to their existing products of digital and 3D mammography systems. These are Philips Healthcare, Canon Medical Systems, and Carestream Health, which aim at advanced imaging techniques, particularly the use of artificial intelligence to facilitate early diagnosis.

Some small companies, such as Planmed Oy Metaltronica, deal with portable or affordable devices in specific areas, and some others, such as IMS Giotto and Dilon Technologies, deal in diagnostic enhancements. Since regional producers target the expanding markets by providing comparatively cheaper ones, competition increases. Partnerships, extensive research and development, and regulatory approval are competitive strategies in this expanding business.

Mammography Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In December 2023, RadNet, Inc. unveiled MammogramNow, a groundbreaking screening service set to launch at Walmart Supercenter in Milford, Delaware, offering convenient access to mammograms.
• In November 2023, GE Healthcare introduced the MyBreastAI Suite, designed to enhance breast cancer detection during mammography. The suite also simplifies radiology workflows by integrating artificial intelligence (AI) tools.
• In September 2023, Siemens Healthineers launched the Mammomat B.brilliant1, a mammography system featuring wide-angle tomosynthesis. The system employs a wide 50° angle, the largest currently available in the market. With a scan time of just five seconds, it provides the fastest wide-angle tomosynthesis, generating high-resolution 3D images quickly.

Report Coverage:

By Device Type

• Analog Mammography Systems
• Digital Mammography Systems
• 3D Mammography Systems
• Others

By Portability

• Stationary Mammography Systems
• Portable Mammography Systems

By End-User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Hologic, Inc.
• Siemens Healthineers AG
• GE HealthCare
• Fujifilm Holdings Corporation
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Carestream Health
• Planmed Oy
• IMS Giotto
• Metaltronica SpA
• Dilon Technologies, Inc.
• Analogic Corporation
• General Medical Merate S.p.A.
• I.M.S. Srl
• SuperSonic Imagine
• Barco NV

Frequently Asked Questions (FAQs)